Head-to-head · WeighScore
Big Easy Weight Loss vs Peter MD
By GLP-1 ScorecardUpdated
Score comparison
Peter MD has the higher recorded score — 78.1/100 to 75.3/100.
Peter MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Peter MD advertises B12 injection packages with consultations, supplies and shipping, but its public price displays differ and the ongoing GLP-1 charge needs a written quote.
Before you choose
Before comparing the headline prices, the Big Easy Weight Loss review and the Peter MD review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Big Easy Weight Loss vs Piper and Care Clinics vs Peter MD compare each of them with another graded program, and the list of alternatives to Big Easy Weight Loss ranks the programs closest to Big Easy Weight Loss on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Big Easy Weight Loss | Peter MD |
|---|---|---|
| WeighScore | 75.3/100 | 78.1/100 |
| Grade | C | C+ |
| Site position | #58 | #32 |
| Semaglutide | $495 per 12 weeks; pricing also shows $399 starter/$495 regular, with pharmacy-specific options. | From $149/month advertised with B12; other page prices differ; confirm charge and renewal |
| Tirzepatide | $599 per 12 weeks on the product page; pricing starts at $469 for a separate pharmacy-specific offer. | From $149/month with B12; $100 off first month advertised; renewal unconfirmed |
| Coverage | All-states claim; confirm physician eligibility and pharmacy shipping restrictions. | Confirm availability for the specific GLP-1 prescription and shipping state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #58 · C
Strengths
- Publishes package and starter prices for comparison before requesting a pharmacy-specific quote.
- Lists pharmacy shipping restrictions; published turnaround ranges differ.
- Names its partner compounding pharmacies and a Chief Medical Officer
What to consider
- Priced as 10 to 12-week packages rather than a simple monthly fee
- New-patient pricing is promotional and may rise on renewal
Site position #32 · C+
Strengths
- Dedicated offers advertise consultations, supplies, shipping and membership together
- Public pages name pharmacy possibilities and disclose an email cancellation window
- Laboratory testing is advertised at 50% off
What to consider
- Starting prices do not establish the renewal; main-site price displays differ
- Specific GLP-1 state eligibility, assigned clinician and dispensing pharmacy remain unconfirmed
- Labs are discounted rather than free; GLP-1-specific monitoring and total testing cost remain unclear
- Auto-renewal cancellation requires at least 48 hours’ email notice; sales are final once medication is received
- Clinical rejection and unused-prepayment refund terms remain unresolved
Featured provider
Peter MD
Peter MD scores 78.1/100 (C+). Peter MD advertises B12 injection packages with consultations, supplies and shipping, but its public price displays differ and the ongoing GLP-1 charge needs a written quote.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.